Mkts

DNA X, Inc.

NASDAQ: SONM
$1.51-0.15 (-9.30%)
As of Nov 20, 2:46 PM ET

Key statistics

Day range
1.471.67
52-week range
1.579.54
Today
Open1.67
Previous close1.51
Volume338
Valuation
Market cap2.24M
P/E ratio6.59×
EPS (TTM)-0.74
Income & risk
Dividend / yield—
Beta2.00
Avg volume15.6K
Discussion

SONM News

Stories mentioning SONM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue(44,125)16,21411,19016,72115,26315,02211,516
Cost of Goods Sold(33,108)14,39810,3458,36515,16710,7908,547
Gross Profit0.00(11,017)1,816845.008,356(183.00)4,2322,969
Operating Expenses
Research & Development(2,723)181.00909.001,63312,507715.00557.00
Sales General & Admin
Total Operating Expenses3,618(8,837)5,7967,577870.00(18,538)6,6089,439
Operating Income (Loss)(3,618)6,176(3,980)(6,732)(870.00)8,435(2,376)(6,470)
Interest Income
Interest Expense131.00374.00339.00161.0071.00
Other Expense48.00(562.00)(161.00)(215.00)36.00449.00(19.00)(92.00)
Pretax Income(3,928)5,005(4,663)(7,336)(961.00)8,872(2,395)(6,579)
Tax Provision2,538(1,507)90.00139.00132.00(53.00)117.0037.00
Net Income (Loss)6,340(8,887)(4,753)(7,475)458.00(21,614)(2,512)(6,616)
Earnings Per Share (Basic)5.01(12.29)(4.83)(0.79)1.41(82.50)(9.32)(1.41)
Earnings Per Share (Diluted)5.01(12.29)(4.83)(0.79)1.41(82.50)(9.32)(1.41)
Weighted Average Shares Outstanding (Basic)1,265723.00985.009,511324.00262.00269.004,685
Weighted Average Shares Outstanding (Diluted)1,265723.00985.009,511324.00262.00269.004,685

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About SONM

DNA X, Inc. (NASDAQ: SONM) is a stock listed on the Nasdaq Stock Market under the ticker symbol SONM. It last traded at $1.51 (Nov 20, 2026, 2:46 PM ET), down 9.3% on the day. That gives DNA X a market capitalisation of $2.2M and a price-to-earnings ratio of 6.6.

Over the past 52 weeks SONM has traded between $1.57 and $9.54.

Net income for the quarter ended Mar 31, 2026 was $6.3M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—$6.3M—
Dec 31, 2025-$44.1M-$8.9M—
Sep 30, 2025$16.2M-$4.8M-29.3%
Jun 30, 2025$11.2M-$7.5M-66.8%

From DNA X’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…